The Cooper Companies, Inc.
COO Healthcare Medical Instruments & Supplies
The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow COO
The Cooper Companies, Inc. (COO) Net income
The Cooper Companies, Inc.'s net income for fiscal 2025 was $374.9M, unchanged from fiscal 2024. Over the twelve months to 31 July 2026 it was $570.3M. Over the past ten years it has ranged from $139.9M (fiscal 2018) to $2.9B (fiscal 2021); the current reading is higher than 64% of that period. The Cooper Companies, Inc. ranks 7th of 54 Medical Instruments & Supplies companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $374.9M | (4.44%) |
| FY2024 | $392.3M | 33.34% |
| FY2023 | $294.2M | (23.74%) |
| FY2022 | $385.8M | (86.90%) |
| FY2021 | $2.9B | 1,135.19% |
| FY2020 | $238.4M | (48.92%) |
| FY2019 | $466.7M | 233.60% |
| FY2018 | $139.9M | (62.48%) |
| FY2017 | $372.9M | 35.65% |
| FY2016 | $274.9M | 34.03% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jul 2026 | $432.8M | — |
| Apr 2026 | −$77.9M | — |
| Jan 2026 | $130.8M | 54.61% |
| Oct 2025 | $84.6M | (13.94%) |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| SOLV Solventum Corporation compare | $1.4B |
| COO The Cooper Companies, Inc. | $570.3M |
| ALGN Align Technology, Inc. compare | $413.6M |
| ATR AptarGroup, Inc. compare | $362.9M |
| RGEN Repligen Corporation compare | $41.5M |
| BLCO Bausch + Lomb Corporation compare | −$163.0M |
| AVTR Avantor, Inc. compare | −$578.0M |
| TFX Teleflex Incorporated compare | −$1.0B |
| BAX Baxter International Inc. compare | −$1.1B |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on COO
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement